ArticleSmall (Weinheim an der Bergstrasse, Germany)2025
Multi-Functional Polydopamine-Mucin Hollow Particles Provide Tunable Shell Permeability, ROS Scavenging, Tissue Adhesion, and Lubricity for Biomedical Applications.
Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dynamic Nanoscavengers With Boosted Antioxidative Properties for Hepatic Ischemia-Reperfusion Injury Therapy.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Multi-Functional Polydopamine-Mucin Hollow Particles Provide Tunable Shell Permeability, ROS Scavenging, Tissue Adhesion, and Lubricity for Biomedical Applications.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Owing to their high drug loading capacity and the option to functionalize their shells, hollow particles (HPs) have emerged as versatile platforms for diagnostic and therapeutic applications. However, those two key advantages of HPs are not yet well leveraged. Often, the large volume within the shells is not fully utilized as a consequence of the employed drug loading methods, and to date, only a limited range of functionalities can be successfully implemented into the shells of HPs. Here, the self-polymerization and adhesion behavior of dopamine are utilized, for the first time, to fabricate polydopamine (PDA)-mucin HPs using a template-based method. By adopting molecules or ions as "locks" to adjust the permeability of the shells, cargo molecules can be trapped within the shells with high encapsulation efficiency. Moreover, owing to the intrinsic properties of PDA and mucins, the shells exhibit multiple functionalities in vitro and ex vivo, including free radical scavenging, tissue adhesion, lubrication, and wear prevention. This study presents a facile method to produce multi-functional PDA-based HPs from a range of (bio)polymers, thus facilitating potential applications of HPs for the treatment of certain diseases, including osteoarthritis and mouth ulcers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.